Shenzhen Salubris Pharmaceuticals Co., Ltd.
002294.SZFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
562
Cost of Revenue
159
Gross Profit
402
Gross Margin
71.6%
Operating Income
90
Operating Margin
16.1%
Net Income
84
Net Margin
15.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
146
EBITDA Margin
26.0%
2023
12/31/2023
Revenue
471
Cost of Revenue
149
Gross Profit
322
Gross Margin
68.3%
Operating Income
92
Operating Margin
19.5%
Net Income
81
Net Margin
17.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
125
EBITDA Margin
26.5%
2022
12/31/2022
Revenue
487
Cost of Revenue
140
Gross Profit
347
Gross Margin
71.3%
Operating Income
102
Operating Margin
20.9%
Net Income
89
Net Margin
18.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
122
EBITDA Margin
25.1%
2021
12/31/2021
Revenue
428
Cost of Revenue
114
Gross Profit
315
Gross Margin
73.5%
Operating Income
82
Operating Margin
19.2%
Net Income
75
Net Margin
17.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
112
EBITDA Margin
26.1%
2020
12/31/2020
Revenue
383
Cost of Revenue
119
Gross Profit
265
Gross Margin
69.0%
Operating Income
11
Operating Margin
2.9%
Net Income
9
Net Margin
2.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
77
EBITDA Margin
20.2%